Mesenchymal Tumors of the Liver: From Basic Research to New Therapies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Tumor Cell Biology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 74
Special Issue Editor
Interests: hepatocellular carcinoma; primary liver cancer; precancerous conditions; carcinogen-esis; surgical pathology; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue “Mesenchymal Tumors of the Liver: From Basic Research to New Therapies” focuses on basic research, pathology, diagnostic imaging, molecular genetics, clinical features, and novel therapeutic approaches.
Mesenchymal tumors of the liver are a diverse group of benign and malignant tumors that may or may not exhibit specific mesenchymal differentiation. They pose significant diagnostic challenges due to their rarity and morphologic overlap with non-mesenchymal lesions in the liver. Accurate diagnosis and therapeutic strategies are essential for appropriate patient treatment and prognosis. Recent advances in molecular pathology, pathogenesis, histopathology, and therapeutic targets in liver mesenchymal tumors have improved our understanding of liver mesenchymal tumors.
This Special Issue is open for basic and clinical research on mesenchymal tumors or a multidisciplinary approach. It will cover original articles and reviews on the following topics: mesenchymal tumors of the liver, molecular biology, tumorigenesis, diagnostic imaging, histopathology, and therapeutic approaches.
Prof. Dr. Joon Hyuk Choi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesenchymal tumors
- liver
- diagnostic imaging
- molecular biology
- pathology
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
